NPI: 1427296433 · LOS ALAMITOS, CA 90720 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/29/2009
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 01/29/2009 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,603 | $319K |
| 2019 | 2,367 | $126K |
| 2020 | 5,348 | $211K |
| 2021 | 12,181 | $412K |
| 2022 | 10,578 | $491K |
| 2023 | 4,616 | $573K |
| 2024 | 3,030 | $429K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 19,256 | 1,668 | $2.25M |
| A4657 | Syringe, with or without needle, each | 1,139 | 614 | $214K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,353 | 614 | $47K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 490 | 317 | $31K |
| J1756 | Injection, iron sucrose, 1 mg | 2,555 | 650 | $13K |
| 0250 | 338 | 53 | $7K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,870 | 426 | $2K |
| 82728 | 204 | 178 | $779.72 | |
| 83970 | 343 | 266 | $100.88 | |
| 83550 | 208 | 177 | $20.97 | |
| 83540 | 208 | 177 | $15.76 | |
| 85048 | 341 | 277 | $13.71 | |
| 85041 | 401 | 334 | $13.57 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 17 | 12 | $0.00 |